1. Home
  2. INTT vs QNCX Comparison

INTT vs QNCX Comparison

Compare INTT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$14.40

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
167.0M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
INTT
QNCX
Price
$14.40
$0.10
Analyst Decision
Strong Buy
Hold
Analyst Count
2
3
Target Price
$13.50
$10.00
AVG Volume (30 Days)
145.8K
16.6M
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$6.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.06
N/A
52 Week Low
$5.24
$0.08
52 Week High
$15.01
$4.55

Technical Indicators

Market Signals
Indicator
INTT
QNCX
Relative Strength Index (RSI) 71.87 28.47
Support Level $7.21 $0.09
Resistance Level $15.01 $0.98
Average True Range (ATR) 0.90 0.01
MACD -0.04 0.07
Stochastic Oscillator 80.45 28.17

Price Performance

Historical Comparison
INTT
QNCX

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: